KRAS and colorectal carcinoma: In summary, our findings reveal an increased prevalence of biallelic MUTYH carriers among CRC patients with the KRAS‐G12C somatic mutation, underscoring that its detection should prompt MUTYH genetic testing, even in the absence of a family history of CRC or a polyposis condition.